title: Glycosaminoglycan destabilization of DNA-chitosan polyplexes for gene delivery depends on chitosan chain length and GAG properties.
abstract: Chitosan-based gene delivery systems are promising candidates for non-viral gene therapy. A wide range of chitosans has been studied to optimize the properties of the DNA-chitosan complexes to yield high transfection efficiencies. An important parameter to control is the polyplex stability to allow transport towards the cells, subsequent internalization and release of DNA intracellularly. The stability of the DNA-chitosan complexes was here studied after exposure to heparin and hyaluronic acid (HA) using atomic force microscopy (AFM) and ethidium bromide (EtBr) fluorescence assay. To study the effect of polycation chain length on the polyplex stability, chitosans with a degree of polymerization (DP) varying from approximately 10 to approximately 1000 were employed for DNA compaction. Whereas HA was unable to dissociate the complexes, the degree of dissociation caused by heparin depended on both the chitosan chain length and the amount of chitosan used for complexation. When increasing the chitosan concentration, larger heparin concentrations were required for polyplex dissociation. Furthermore, increasing the chitosan chain length yielded more stable complexes. Varying the chitosan chain length thus provides a tool for controlling the ability of the polyplex to deliver therapeutic gene vectors to cells.
authors.affiliation: Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, Hogskoleringen 5, NTNU, NO-7491 Trondheim, Norway.
authors.forename: Signe
authors.initials: S
authors.lastname: Danielsen
authors.forename: Sabina
authors.initials: S
authors.lastname: Strand
authors.forename: Catharina
authors.initials: C
authors.lastname: de Lange Davies
authors.forename: Bjørn T
authors.initials: BT
authors.lastname: Stokke
mesh_terms: D048271:Chitosan / Q000737:chemistry*; D004247:DNA / Q000737:chemistry*; D016503:Drug Delivery Systems; D015316:Genetic Therapy; D006025:Glycosaminoglycans / Q000494:pharmacology*; D018625:Microscopy, Atomic Force
chemical_list: D006025:Glycosaminoglycans; D004247:DNA; D048271:Chitosan